In a recent study, Thudi et al. [130] reported that DKK1 significantly increased Ace-1 subcutaneous tumor mass and the incidence of bone metastases after intracardiac injection of Ace-1 prostate cancer cells. This evidence concerns the gene ACE and prostate carcinoma.